How Does Hydroxyurea Work for Sickle Cell?
At a Glance
Hydroxyurea is a daily pill for sickle cell disease that prevents sickling by prompting the body to make smooth, healthy fetal hemoglobin. It reduces inflammation, prevents severe pain crises, lowers the risk of lung complications, and leads to fewer hospital visits when taken consistently.
In this answer
6 sections
Hydroxyurea is a convenient, once-daily oral pill that is one of the most important medications for managing sickle cell disease [1]. Rather than just treating pain after it starts, hydroxyurea works directly on your blood cells as a preventative measure to stop sickling before it happens [2]. It primarily prompts your body to produce a special oxygen-carrying protein called fetal hemoglobin (HbF) [2]. By increasing HbF levels, hydroxyurea significantly reduces pain crises, protects your lungs, and improves your overall quality of life [3].
Is Hydroxyurea Chemotherapy?
Many patients are hesitant to start hydroxyurea because they hear it referred to as “chemo.” Hydroxyurea is indeed classified as an antineoplastic (chemotherapy) medication [4]. However, in sickle cell disease, it is used as a “disease-modifying” therapy at much lower doses than what is used to treat cancer [1]. Because the dose is so much lower, you typically will not experience the severe side effects associated with cancer treatments, such as profound hair loss or severe, debilitating nausea.
The Power of Fetal Hemoglobin
Everyone is born with fetal hemoglobin, which helps babies get oxygen in the womb. Fetal hemoglobin is smooth, round, and does not tangle or “sickle.” Normally, our bodies stop making HbF shortly after birth and switch to adult hemoglobin. In people with sickle cell disease, the body produces an abnormal form of adult hemoglobin that is prone to sickling [2].
Hydroxyurea essentially “wakes up” the system that makes fetal hemoglobin [5]. When you take it daily, your red blood cells become packed with this smooth, healthy HbF instead of the sickling adult hemoglobin [6]. Because HbF prevents the red blood cells from turning into stiff, sticky sickles, the cells can flow freely and carry oxygen easily through your blood vessels [2].
Calming Inflammation
In addition to boosting fetal hemoglobin, hydroxyurea helps by gently reducing the number of white blood cells in your bloodstream [6]. In sickle cell disease, extra white blood cells can increase inflammation and make your blood vessels sticky, causing red blood cells to clump together and block blood flow [7]. By lowering these white blood cells, hydroxyurea calms this inflammation and makes it easier for blood to circulate smoothly [8].
Real-World Benefits
Because it treats the root causes of sickling, hydroxyurea provides benefits that go far beyond basic pain relief:
- Fewer Pain Crises: It significantly reduces the frequency of vaso-occlusive crises (severe pain episodes caused by blocked blood vessels) [3][9].
- Protection Against Acute Chest Syndrome: It lowers the risk of acute chest syndrome, a dangerous lung complication that often leads to hospitalization [3].
- Fewer Hospital Visits: As a preventative therapy, it means fewer emergency room visits, fewer blood transfusions, and less time in the hospital [10][11].
- A Longer, Healthier Life: Long-term use of hydroxyurea reduces sickle cell-related organ damage and extends lifespan [12][13].
How Long Does It Take to Work?
Because hydroxyurea works by fundamentally changing how your bone marrow produces blood cells, it is not a quick fix. It typically takes 3 to 6 months of daily use for your body to build up enough fetal hemoglobin to experience the full clinical benefits [5]. It is absolutely crucial to continue taking the pill every single day, even if you do not feel better immediately.
What About Side Effects?
Decades of research show hydroxyurea has a strong safety profile, but it does have side effects that require monitoring [14].
- Day-to-Day Side Effects: Some patients experience mild stomach upset, nausea, or fatigue when starting the medication [15]. You might also notice mild hair thinning or hyperpigmentation (a harmless darkening of your skin and fingernails).
- Lower Blood Counts: The most common clinical side effect is a drop in white blood cells (neutropenia) or platelets [6]. Your hematologist will check your blood frequently to ensure your dose is safe. If your counts drop too low, your doctor will adjust your dose or temporarily pause the medication [15].
- Fertility Impacts for Men and Women: Hydroxyurea can lower sperm counts and quality in men [16]. In women, it may reduce ovarian reserves (egg counts), as measured by lower anti-Müllerian hormone (AMH) levels [17]. If you plan to have children in the future, discuss fertility preservation (like sperm or egg banking) with your doctor before starting treatment.
- Pregnancy: While historically avoided during pregnancy, newer data suggests the risks are lower than previously thought, especially when weighed against the severe dangers of an untreated sickle cell crisis during pregnancy [18][19]. Always discuss family planning with your care team.
Common questions in this guide
Is hydroxyurea a type of chemotherapy?
How does fetal hemoglobin help with sickle cell disease?
How long does it take for hydroxyurea to start working?
Can hydroxyurea affect my ability to have children?
What are the side effects of taking hydroxyurea for sickle cell?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is my current fetal hemoglobin (HbF) level, and what is our target goal with this medication?
- 2.How frequently will I need to have my blood drawn to monitor for neutropenia or other lab changes?
- 3.Are there fertility preservation options, such as sperm or egg freezing, that I should pursue before starting hydroxyurea?
- 4.What should I do if I miss a dose or if I experience stomach upset after taking my daily pill?
- 5.Given my specific medical history, are there any additional long-term side effects I should be particularly watchful for?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (19)
- 1
Hydroxyurea for hemoglobin E/β-thalassemia: a systematic review and meta-analysis.
Algiraigri AH, Kassam A
International journal of hematology 2017; (106(6)):748-756 doi:10.1007/s12185-017-2307-0.
PMID: 28786080 - 2
Impact of Hydroxyurea on Clinical and Biological Parameters of Sickle Cell Anemia in Children in Abidjan.
Yayo-Aye M, Adjambri AE, Kouakou B, et al.
Mediterranean journal of hematology and infectious diseases 2024; (16(1)):e2024026 doi:10.4084/MJHID.2024.026.
PMID: 38468842 - 3
Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.
Di Maggio R, Hsieh MM, Zhao X, et al.
International journal of molecular sciences 2018; (19(3)) doi:10.3390/ijms19030681.
PMID: 29495591 - 4
In Vitro/In Vivo Evaluation of Radiolabeled [(99m)Tc(CO)3](+)-Hydroxyurea and Fluorescein Isothiocyanate-Hydroxyurea.
Yilmaz B, Teksoz S, Kilcar AY, et al.
Cancer biotherapy & radiopharmaceuticals 2016; (31(1)):14-9 doi:10.1089/cbr.2015.1886.
PMID: 26844848 - 5
Decreased fetal hemoglobin over time among youth with sickle cell disease on hydroxyurea is associated with higher urgent hospital use.
Green NS, Manwani D, Qureshi M, et al.
Pediatric blood & cancer 2016; (63(12)):2146-2153 doi:10.1002/pbc.26161.
PMID: 27573582 - 6
Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).
Wang WC, Ware RE, Miller ST, et al.
Lancet (London, England) 2011; (377(9778)):1663-72 doi:10.1016/S0140-6736(11)60355-3.
PMID: 21571150 - 7
Hydroxyurea and Zileuton Differentially Modulate Cell Proliferation and Interleukin-2 Secretion by Murine Spleen Cells: Possible Implication on the Immune Function and Risk of Pain Crisis in Patients with Sickle Cell Disease.
Kuvibidila S, Warrier RP, Haynes J, Baliga SB
Ochsner journal 2015; (15(3)):241-7.
PMID: 26412995 - 8
Serum of sickle cell disease patients contains fetal hemoglobin silencing factors secreted from leukocytes.
Ikuta T, Sellak H, Liu SY, Odo N
Journal of blood medicine 2018; (9()):95-104 doi:10.2147/JBM.S156999.
PMID: 29950916 - 9
Adherence to hydroxyurea and clinical outcomes among children with sickle cell anemia.
Reeves SL, Dombkowski KJ, Peng HK, et al.
Pediatric blood & cancer 2023; (70(7)):e30332 doi:10.1002/pbc.30332.
PMID: 37046404 - 10
Morbidity pattern and impact of hydroxyurea therapy among sickle cell patients in Raipur district of Chhattisgarh.
Vaibhav D, Panda PS, Debata I, Sinha AK
Journal of family medicine and primary care 2024; (13(5)):1825-1829 doi:10.4103/jfmpc.jfmpc_1490_23.
PMID: 38948632 - 11
Hydroxyurea Use Among Children With Sickle Cell Disease at King Abdulaziz University Hospital in Jeddah City.
Alzahrani F, Albaz GF, AlSinan F, et al.
Cureus 2021; (13(2)):e13453 doi:10.7759/cureus.13453.
PMID: 33767937 - 12
Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: The last 40 years.
Chaturvedi S, DeBaun MR
American journal of hematology 2016; (91(1)):5-14 doi:10.1002/ajh.24235.
PMID: 26547630 - 13
Hydroxyurea utilization among individuals with sickle cell disease in Tennessee: a pooled analysis of claims data.
Mukhopadhyay A, Smeltzer MP, Dudley J, et al.
Frontiers in pharmacology 2025; (16()):1693126 doi:10.3389/fphar.2025.1693126.
PMID: 41487491 - 14
Hydroxyurea: Clinical and Hematological Effects in Patients With Sickle Cell Anemia.
Keikhaei B, Yousefi H, Bahadoram M
Global journal of health science 2015; (8(3)):252-6 doi:10.5539/gjhs.v8n3p252.
PMID: 26493428 - 15
Hydroxyurea Pharmacokinetic Evaluation in Patients with Sickle Cell Disease.
Di Grazia D, Mirabella C, Chiara F, et al.
Pharmaceuticals (Basel, Switzerland) 2024; (17(10)) doi:10.3390/ph17101386.
PMID: 39459025 - 16
Study of Seminal Fluid Parameters and Fertility of Male Sickle Cell Disease Patients and Potential Impact of Hydroxyurea Treatment.
Sahoo LK, Kullu BK, Patel S, et al.
The Journal of the Association of Physicians of India 2017; (65(6)):22-25.
PMID: 28782309 - 17
Effects of hydroxyurea on fertility in male and female sickle cell disease patients. A systemic review and meta-analysis.
Sewaralthahab S, Alsubki LA, Alhrabi MS, Alsultan A
PloS one 2024; (19(6)):e0304241 doi:10.1371/journal.pone.0304241.
PMID: 38848387 - 18
Safety of Hydroxyurea in Pregnancy: A Systematic Review of the Literature.
Al Sulaimani R, Zitoun N, Alothman H, et al.
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2025; (47(7)):102924 doi:10.1016/j.jogc.2025.102924.
PMID: 40381805 - 19
Lower rates of maternal morbidities among pregnant women suffering from sickle cell disease who are exposed to hydroxyurea, a retrospective study from tribal area of Western India.
Desai G, Balar H, Dave K, Desai S
Expert review of hematology 2025; (18(12)):1099-1105 doi:10.1080/17474086.2025.2562080.
PMID: 40947623
This page explains how hydroxyurea works for sickle cell disease for educational purposes only. Always consult your hematologist regarding your specific treatment plan, side effects, and fertility concerns.
Get notified when new evidence is published on Sickle cell anemia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.